NCT04419623
- Conditions
- Blood Cancer, COVID-19, Cancer, +21 more
- Locations
-
- Georgia Cancer Center Augusta, Georgia, United States
- The Ohio State Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Solid Tumor
Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.
729 public trials
250 recruiting studies
Solid Tumor trial results
Completed
Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor
NCT03406364
- Conditions
- Solid Tumor
- Locations
-
- Tri-Service General Hospital Taipei, Nehu District, Taiwan
NCT02953782
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
- Locations
-
- UCLA Los Angeles, California, United States
- Stanford University Palo Alto, California, United States
- Wayne State University Detroit, Michigan, United States
- START Midwest Grand Rapids, Michigan, United States
NCT02273739
- Conditions
- Adenocarcinoma, Angioimmunoblastic T-cell Lymphoma, Carcinoma, +22 more
- Locations
-
- Los Angeles, California, United States
- Los Angeles, California, United States
- Miami, Florida, United States
- Baltimore, Maryland, United States
NCT03489369
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT00786669
- Conditions
- Solid Tumor
- Locations
-
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
NCT02132754
- Conditions
- Solid Tumor
- Locations
-
Not specified
Completed
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
NCT01432951
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
NCT01337765
- Conditions
- Breast Diseases, Breast Neoplasms, Digestive System Diseases, +12 more
- Locations
-
- Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States
- University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States
- Pfizer Investigative Site Parkville, Victoria, Australia
- Pfizer Investigative Site Toronto, Ontario, Canada
NCT03712423
- Conditions
- Neoplasms, Solid Tumor
- Locations
-
- VU University Medical Center Amsterdam, North Holland, Netherlands